ANI Pharmaceuticals, Inc.
Symbol: ANIP (NASDAQ)
Company Description:
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
- Today's Open: $95.43
- Today's High: $96.329
- Today's Low: $93.074
- Today's Volume: 198.03K
- Yesterday Close: $95.38
- Yesterday High: $95.9399
- Yesterday Low: $93.518
- Yesterday Volume: 189.71K
- Last Min Volume: 6
- Last Min High: $94
- Last Min Low: $94
- Last Min VWAP: $94
- Name: ANI Pharmaceuticals, Inc.
- Website: https://www.anipharmaceuticals.com
- Listed Date: 1999-09-13
- Location: BAUDETTE, MN
- Market Status: Active
- CIK Number: 0001023024
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $2.13B
- Round Lot: 100
- Outstanding Shares: 22.29M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | SCHEDULE 13G/A | View |
| 2025-10-14 | 4 | View |
| 2025-09-26 | 8-K | View |
| 2025-09-22 | 4 | View |
| 2025-09-15 | 4 | View |
| 2025-09-15 | 4 | View |
| 2025-09-08 | 8-K | View |
| 2025-09-04 | 4 | View |
| 2025-09-03 | 144 | View |
| 2025-08-26 | 4 | View |
| 2025-08-25 | 144 | View |
| 2025-08-25 | 4 | View |
| 2025-08-22 | 4 | View |
| 2025-08-22 | SCHEDULE 13D/A | View |
| 2025-08-21 | 144 | View |
| 2025-08-20 | 144 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 144 | View |
| 2025-08-19 | 144 | View |